A detailed history of Jacobs Levy Equity Management, Inc transactions in Natera, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 4,333 shares of NTRA stock, worth $733,446. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,333
Previous 56,163 92.28%
Holding current value
$733,446
Previous $7.94 Million 90.78%
% of portfolio
0.0%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$132.23 - $171.87 $6.85 Million - $8.91 Million
-51,830 Reduced 92.28%
4,333 $732,000
Q1 2025

May 15, 2025

BUY
$132.63 - $177.0 $7.45 Million - $9.94 Million
56,163 New
56,163 $7.94 Million
Q3 2018

Nov 14, 2018

SELL
$18.82 - $28.96 $430,037 - $661,736
-22,850 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$8.79 - $19.98 $10,565 - $24,015
1,202 Added 5.55%
22,850 $430,000
Q1 2018

May 15, 2018

BUY
$9.0 - $11.95 $194,832 - $258,693
21,648 New
21,648 $201,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.4B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.